To Be Discontinued Tablet Psychiatry

Desipramine Hydrochloride Ta · 6 active FDA presentation rows for this drug

Brand: DESIPRAMINE HYDROCHLORIDE

FDA lists Desipramine Hydrochloride Ta as To Be Discontinued (Avet Pharmaceuticals, Inc.).

No availability text on this FDA row.

Desipramine Hydrochloride Tablet: To Be Discontinued

FDA availability text is not recorded on this row. 6 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Desipramine Hydrochloride Tablet
Manufacturer
Avet Pharmaceuticals, Inc.
Dosage Form
Tablet
Presentation
Desipramine Hydrochloride, Tablet, 75 mg (NDC 23155-581-01)
Package NDC
23155-581-01

Status & Timeline

Status
To Be Discontinued
First Reported
Aug 12, 2025
Last Updated
Aug 12, 2025
Therapeutic Category
Psychiatry

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Discontinuation of the manufacture of the drug

Full Drug Profile

desipramine

Side effects, interactions, warnings & more

View Profile
Compare desipramine with alternatives →

Nearby, Other Desipramine Shortage Records

Desipramine Hydrochloride Tablet

Avet Pharmaceuticals, Inc.

Tablet

To Be Discontinued

Desipramine Hydrochloride Tablet

Avet Pharmaceuticals, Inc.

Tablet

To Be Discontinued

Desipramine Hydrochloride Tablet

Avet Pharmaceuticals, Inc.

Tablet

To Be Discontinued

Desipramine Hydrochloride Tablet

Avet Pharmaceuticals, Inc.

Tablet

To Be Discontinued

Desipramine Hydrochloride Tablet

Avet Pharmaceuticals, Inc.

Tablet

To Be Discontinued

FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.

← All Drug Shortages